CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale General Counsel sold 1,878 shares at $39.83 ($74,801)
- 4 Planned sale Chief Financial Officer sold 2,170 shares at $39.83 ($86,431)
- 4 Planned sale Kelsey Stephen Michael sold 4,289 shares at $39.83 ($170,831)
- 4 Planned sale Chief Medical Officer sold 2,173 shares at $39.83 ($86,551)
- 4/A Derivatives Options or other derivatives
- 4 Planned sale General Counsel sold 2,041 shares at $38.71 ($79,008)
- 4 Planned sale General Counsel sold 1,458 shares at $39.04 ($56,921)
- 4 Planned sale GOLDSMITH MARK A sold 11,738 shares at $39.04 ($458,255)
- 4 Planned sale Chief Financial Officer sold 1,864 shares at $39.04 ($72,771)
- 4 Planned sale Chief Operating Officer sold 3,058 shares at $39.04 ($119,385)
- 4 Planned sale Kelsey Stephen Michael sold 3,294 shares at $39.04 ($128,599)
- 4 Gift Wang Xiaolin gave 2,718 shares (gift)
- 4 Grant or award General Counsel acquired 22,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,400 shares (grant or award)
- 4 Grant or award Kelsey Stephen Michael acquired 36,600 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 28,600 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,800 shares (grant or award)
- 4 Grant or award Wang Xiaolin acquired 19,000 shares (grant or award)
- 4 Grant or award GOLDSMITH MARK A acquired 97,400 shares (grant or award)
- 4 Planned sale General Counsel sold 2,406 shares at $40.50 ($97,443)
Page 6 of 21 · 414 filings